Corbus Pharma amends employment agreements: CEO salary $673,625, CFO salary $501,273

Corbus Pharmaceuticals Holdings, Inc.

New employment agreements for CEO Yuval Cohen and CFO Sean Moran, effective April 15, 2026.
CEO Cohen: base salary $673,625, bonus target up to 60%, term through April 15, 2028.
CFO Moran: base salary $501,273, bonus target up to 40%, term through April 15, 2028.
CEO severance: 12 months' base salary, COBRA; change-in-control: 24 months, 2x bonus, full vesting.
CFO severance: 12 months' base salary, COBRA; change-in-control: 18 months, 1x bonus, full vesting.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.